By Matt Skoufalos
Cleveland Clinic has named Tomislav Mihaljevic as CEO and president, succeeding Toby Cosgrove on January 1, 2018. Mihaljevic joined Cleveland Clinic in 2004 as a cardiothoracic surgeon; since 2015, he has been CEO of Cleveland Clinic Abu Dhabi. Mihaljevic earned his medical degree from the University of Zagreb in Croatia and moved to the United States in 1995 to join Brigham and Women’s Hospital in Boston. He is the author or co-author of more than 145 articles in medical and peer-reviewed scientific journals, holds a patent for a minimally invasive cardioscopy surgical system, and won the 2006 and 2007 Cleveland Clinic Innovation Awards.
Outcome Health of New York, New York has hired its first Chief Engineering Officer, Nandini Ramani. Ramani was previously at Twitter, where she led engineering effectiveness for the company; she has also led the Java business unit for Oracle.
Lightmed of San Clemente, California has replaced Gary Lee, the company’s founder and CEO, with new CEO Shlomo Alkalay. Lee will continue to serve as the Executive Chairman of the Board. Alkalay joins the company from Syneron-Candela, where he was most recently COO; his resume includes 25-plus years of experience in the medical device field, including in VP roles with Lumenis.
Orion Health of Scottsdale, Arizona has named Terry Macaleer as president. Macaleer succeeds Wayne Oxenham, who will relocate to its corporate headquarters in Auckland, New Zealand. Macaleer co-founded Eclipsys, an EHR company that eventually merged with Allscripts, and subsequently founded Carefx, a clinical and business workflow software company. From 2008-2014, Macaleer was SVP of sales at Allscripts; he has also been SVP of client engagement and sales at Anthelio Healthcare Solutions. Macaleer will join Orion Health’s executive leadership team mid-September and will report to CEO Ian McCrae.
Millennium Health of San Diego, California has named Eugene I. Davis chairman of its board of directors and Jennifer Strickland as CEO and a board member. Current chairman and CEO Ronald A. Rittenmeyer is stepping down into an advisory role through the end of 2017. Strickland, who joined Millennium Health in 2011, has been GM of its pharmacogenetic testing and medication monitoring business lines before rising to the rank of COO. Her career includes hospital leadership roles in pharmacy and pain management, various educator roles, and a residency directorship at the H. Lee Moffitt Cancer Center and Lakeland Regional Medical Center. Strickland holds a doctor of pharmacy degree from the University of Florida College of Pharmacy and has completed a specialty pharmacy residency in pain management at the Moffitt Center.
IPRO of Lake Success, New York, has added policy experts Patricia Simino Boyce, most recently of the CMS Center for Medicare and Medicaid Innovation, and Jennifer N. Edwards, formerly SVP of State Consulting at the Lewin Group. Boyce has been Director of Policy for Care Delivery and Quality Improvement at the Massachusetts Health Policy Commission; she has also worked with the Visiting Nursing Service of New York’s Center for Homecare Policy and Research, the Primary Care Development Corporation of New York, the New York State Department of Health, Ernst & Young and New York-Presbyterian/Lower Manhattan Hospital.
The Washington, D.C.-based Pharmaceutical Research and Manufacturers of America has added Richard A. Moscicki as Chief Medical Officer and EVP. Moscicki was most recently deputy director for science operations at the U.S. Food and Drug Administration Center for Drug Evaluation and Research. Prior to that, he was SVP, head of clinical development, and chief medical officer at Genzyme Corporation, where he worked for nearly 20 years.
CSSi of Glen Burnie, Maryland has added Charlie Speno as VP of Business Development. Speno was previously VP of Business Development at United BioSource Corporation, and has spent nearly 20 years in clinical and sales management in the pharmaceutical, biotech and medical device industries.
Simione Healthcare Consultants of Hamden, Connecticut has named Chad Deterding its VP of business development. Deterding has spent 17 years in the home care, hospice, and private duty healthcare lines, in both account management and business development roles. Most recently, he was regional sales manager for Mediware Information Systems, and has spent 15 years as a business development executive with McKesson Corporation.
electroCore of Basking Ridge, New Jersey has added Publicis Health CEO Nick Colucci to its board of directors, replacing former Cyberonics CEO and co-founder Reese Terry. Colucci joined Publicis as President in 2000, and has also been its COO. He has been VP of Marketing & Sales at EyeSys Technologies, Marketing Director at Roche, and currently serves on the Coalition for Healthcare Communication and board of the American Heart Association of New York.
The Hospital for Special Surgery (HSS) in New York, New York, has named William M. Ricci as chief of the Combined HSS/NYP (New York-Presbyterian) Orthopedic Trauma Service, succeeding David L. Helfet. Ricci has been chief and fellowship director of the Orthopedic Trauma Service, and vice-chair of Orthopaedics at Washington University School of Medicine in St. Louis. He is currently president of the Orthopaedic Trauma Association, has served on the Board of Directors of the American Orthopaedic Association, and was an American-British-Canadian travelling fellow.
William M. Ricci
Keck Graduate Institute of Claremont, California has named Biocon Chair and Managing Director Kiran Mazumdar-Shaw to its Board of Trustees. Mazumdar-Shaw is a pioneer of the biotechnology industry in India who in 2014, established Biocon Academy, a Center of Excellence for Advanced Learning in Biosciences, in 2014. The program develops high-quality biotech talent that addresses the needs of the biotechnology sector in India.